Stockreport

VYNE Therapeutics to Participate in September Investor Conferences

VYNE Therapeutics Inc.  (VYNE) 
PDF BRIDGEWATER, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focus [Read more]